An ultra-endurance event leads to changes in circulating regulatory T-cells, CD4+naïve and CD8+effector memory T-cells in the 48 h post-race recovery period

被引:0
|
作者
Lithgow, Hannah [1 ,2 ]
Gibson, Laura [2 ]
Wilson, Russell [1 ,2 ]
Guthrie, Neil [2 ]
Ingram-Sills, Lesley [2 ]
Clifford, Tom [3 ,4 ]
Ross, Mark [1 ,2 ]
机构
[1] Heriot Watt Univ, Inst Life & Earth Sci, Sch Energy Geosci Infrastruct & Soc, Edinburgh EH14 4AS, Midlothian, Scotland
[2] Edinburgh Napier Univ, Sch Appl Sci, Edinburgh, Scotland
[3] Newcastle Univ, Inst Cellular Med, Newcastle, England
[4] Loughborough Univ, Sch Sport Exercise & Hlth Sci, Loughborough, England
关键词
Endurance; Lymphocytes; Exercise; Adaptive immunity; T-cells; PERIPHERAL-BLOOD COMPARTMENT; SKELETAL-MUSCLE; IMMUNE FUNCTION; EXERCISE; LYMPHOCYTES; INTENSITY; CYTOKINE; ANGIOGENESIS; REGENERATION; MOBILIZATION;
D O I
10.1007/s00421-024-05677-y
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Purpose Exercise is known to acutely affect T-lymphocyte populations in the peripheral blood, which is intensity- and duration-dependent. However, effects of longer duration endurance exercise (>5 h) on T-cells in the days following are unknown. The aim of this study was to investigate the circulating T-cell changes that occur in response to an ultra-endurance event, which may provide insight into the inflammatory response to ultra-endurance exercise. Methods Ten individuals (m = 7, f = 3) completing an Ironman 70.3 event volunteered for the study. Peripheral blood samples were taken 1-2 days pre-race (PRE-RACE), and 1 day (RACE + 1) and 2 days (RACE + 2) post-race, with circulating T-cells enumerated by flow cytometry (total CD3+, CD4+ and CD8+ T-cells, regulatory T-cells [CD4+CD25+CD127-; T-REG], na & iuml;ve [CD27+CD45RA+; NA], central memory [CD27+CD45RA-; CM], effector memory [CD27-CD45RA-; EM], and effector memory CD45RA+ [CD27-CD45RA+; EMRA]). ResultsThere were no changes in total CD3+, CD4+ and CD8+ T-cells. T-REG RACE + 1 was significantly higher compared to PRE-RACE, as were the proportion of CD4+ NA cells and CD8+ CM cells at RACE + 2; CD8+ EM cells fell at RACE + 2 (absolute counts and proportion). Conclusion In conclusion, the ultra-endurance event evoked T-cell changes over the 48 h recovery period, with an increase in T-cells that regulate the immune response, and a reduction in circulating EM T-cells, most likely trafficked to sites of tissue damage and inflammation.
引用
收藏
页码:1129 / 1138
页数:10
相关论文
共 11 条
  • [1] Dasatinib, nilotinib and imatinib inhibit CD8+ effector T-cells as well as CD4+CD25hi regulatory T-cells with different potency
    Chen, J.
    Schmitt, A.
    Fei, F.
    Yu, Y. Z.
    Chen, B.
    von Harsdorf, S.
    Ringhoffer, M.
    Bunjes, D.
    Schmitt, M.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S65 - S66
  • [2] CD45 ISOFORMS OF HUMAN CIRCULATING AND LYMPHOID-TISSUE CD8+ T-CELLS INDICATE MUCH FEWER MEMORY CELLS THAN CD4+ T-CELLS
    TANAKA, Y
    HORGAN, KJ
    LUCE, GEG
    SHAW, S
    FASEB JOURNAL, 1991, 5 (06): : A1687 - A1687
  • [3] Cutaneous CD4+CD8αα+ T-Cells Expressing The CD160 Receptor Are Present In The Circulation As Effector Memory Cytotoxic T-Lymphocytes
    Schmitt, Christian
    Schiavon, Valerie
    Giustiniani, Jerome
    Michel, Laurence
    Bagot, Martine
    Olive, Daniel
    Bensussan, Armand
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 : S86 - S86
  • [4] Peripheral Blood Expansion of CD38 Bright CD8+Effector Memory T-Cells Predicts Acute Graft Versus Host Disease with a Diagnostic Accuracy of 87%
    Khandelwal, Pooja
    Lane, Adam
    Owsley, Erika
    Chaturvedi, Vijaya
    Jordan, Michael B.
    Davies, Stella M.
    Marmer, Daniel J.
    Filipovich, Alexandra
    Marsh, Rebecca A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S99 - S101
  • [5] IL7 administration in humans results in preferential expansion of naive and memory CD4+ & CD8+T cells with a relative decrease in regulatory T-cells (T-regs).
    Sportes, Claude
    Krumlauf, Michael
    Babb, Rebecca
    Foruraghi, Ladan
    Daub, Janine
    Avila, Daniele
    Chow, Catherine
    Zhang, Hua
    Chua, Kevin
    Fry, Terry
    Memon, Sarfraz
    Hakim, Frances
    Fleisher, Thomas
    Brown, Margaret
    Engel, Julie
    Buffet, Renaud
    Morre, Michel
    Gress, Ronald
    Mackall, Crystal
    BLOOD, 2006, 108 (11) : 261A - 261A
  • [6] α4β7 Integrin Is Upregulated on CD8+Effector Memory T-Cells in Children with Gut Gvhd Prior to Clinical Symptoms and Represents a Therapeutic Target in Pediatric Allogeneic HSCT Patients
    Khandelwal, Pooja
    Davies, Stella M.
    Jordan, Michael B.
    Lake, Kelly E.
    Litts, Bridget
    Owsley, Erika
    Marsh, Rebecca A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [7] Differences in up-regulated CCR5 and CCR3 expression on CD4+ and CD8+ effector memory T-cells in localized and generalized WG.
    Lamprecht, P
    Erdmann, A
    Mueller, A
    Csernok, E
    Reinhold-Keller, E
    Holl-Ulrich, K
    Feller, AC
    Gross, WL
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S386 - S387
  • [8] Differential susceptibility of B-cells and protective CD8 and CD4 T-cells leads to low incidence of post-transplant EBV-related disease after alemtuzumab-based T-cell depletion
    Halkes, C. J. M.
    Jedema, I.
    van Egmond, H. M.
    Wolbers, J. Olde
    Borne, P. A. von Dem
    Marijt, E. W.
    Falkenburg, J. H. F.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S81 - S81
  • [9] Virus-specific CD4+ and CD8+ memory T-cells in young volunteers after immunization with pandemic live attenuated reassortant influenza vaccines A (H5N2) and A (H1N1)
    Naykhin, Anatoly
    Petukhova, Galina
    Chirkova, Tatiana
    Korenkov, Daniil
    Donina, Svetlana
    Rudenko, Larisa
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2011, 5 : 195 - 198
  • [10] Low incidence of viral complications after in vivo and in vitro T-cell depletion using low dose alemtuzumab is due to early post transplant outgrowth of protective virus specific CD4 and CD8 memory T-cells by various escape mechanisms
    Halkes, C.
    Falkenburg, J. H. F.
    van Egmond, E.
    van Meent, M.
    von dem Borne, P.
    Marijt, W. A. F.
    Veelken, J. H.
    Jedema, I.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S31 - S31